President-elect Trump's plan to enact heavy tariffs on certain imports could affect the prices and availability of pharmaceutical drugs in the U.S.
Trump has floated 25 percent tariffs on imports from Mexico and Canada, as well as expanded tariffs on Chinese imports. Economists have warned that such tariffs will drive prices up, and Trump acknowledged earlier this month he "can't guarantee" they won't increase costs for consumers.
When it comes to drugs, health care industry...